ATE458743T1 - Zwischenprodukt und verfahren zur herstellung von an beta-anomeren angereicherten 2'-desoxy,2',2'- difluor-d-ribufuranosylnukleosiden - Google Patents

Zwischenprodukt und verfahren zur herstellung von an beta-anomeren angereicherten 2'-desoxy,2',2'- difluor-d-ribufuranosylnukleosiden

Info

Publication number
ATE458743T1
ATE458743T1 AT05794951T AT05794951T ATE458743T1 AT E458743 T1 ATE458743 T1 AT E458743T1 AT 05794951 T AT05794951 T AT 05794951T AT 05794951 T AT05794951 T AT 05794951T AT E458743 T1 ATE458743 T1 AT E458743T1
Authority
AT
Austria
Prior art keywords
ribufuranosyl
nucleosids
difluor
desoxy
anomeric
Prior art date
Application number
AT05794951T
Other languages
English (en)
Inventor
Golak Chandra Maikap
Deependra Bhatt
Bijan Kumar Panda
Original Assignee
Fresenius Kabi Oncology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35457749&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE458743(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fresenius Kabi Oncology Ltd filed Critical Fresenius Kabi Oncology Ltd
Application granted granted Critical
Publication of ATE458743T1 publication Critical patent/ATE458743T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT05794951T 2005-03-04 2005-09-23 Zwischenprodukt und verfahren zur herstellung von an beta-anomeren angereicherten 2'-desoxy,2',2'- difluor-d-ribufuranosylnukleosiden ATE458743T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN472DE2005 2005-03-04
PCT/IN2005/000322 WO2006092808A1 (en) 2005-03-04 2005-09-23 Intermediate and process for preparing of beta- anomer enriched 21deoxy, 21 ,21-difluoro-d-ribofuranosyl nucleosides

Publications (1)

Publication Number Publication Date
ATE458743T1 true ATE458743T1 (de) 2010-03-15

Family

ID=35457749

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05794951T ATE458743T1 (de) 2005-03-04 2005-09-23 Zwischenprodukt und verfahren zur herstellung von an beta-anomeren angereicherten 2'-desoxy,2',2'- difluor-d-ribufuranosylnukleosiden

Country Status (24)

Country Link
US (2) US7235647B2 (de)
EP (1) EP1853616B1 (de)
JP (1) JP2008531680A (de)
KR (1) KR20070112774A (de)
CN (1) CN101203524B (de)
AP (1) AP2219A (de)
AR (1) AR052860A1 (de)
AT (1) ATE458743T1 (de)
AU (1) AU2005328519B2 (de)
BR (1) BRPI0520050A2 (de)
CA (1) CA2598895A1 (de)
CL (1) CL2005003456A1 (de)
DE (1) DE602005019626D1 (de)
EA (1) EA011558B1 (de)
ES (1) ES2341663T3 (de)
GE (1) GEP20094822B (de)
IL (1) IL184957A (de)
MX (1) MX2007010316A (de)
MY (1) MY141378A (de)
NZ (1) NZ560735A (de)
TW (1) TWI333493B (de)
UA (1) UA88940C2 (de)
WO (1) WO2006092808A1 (de)
ZA (1) ZA200706392B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006092808A1 (en) * 2005-03-04 2006-09-08 Dabur Pharma Limited Intermediate and process for preparing of beta- anomer enriched 21deoxy, 21 ,21-difluoro-d-ribofuranosyl nucleosides
WO2008026222A2 (en) * 2006-08-28 2008-03-06 Shilpa Medicare Ltd Process and intermediates of 2,2' difluoronucleosides
KR100846143B1 (ko) 2007-02-28 2008-07-14 (주) 유일팜테크 2'-데옥시-2',2'-디플루오로시티딘의 전구체 및 그의제조방법
CN102093451A (zh) * 2009-12-12 2011-06-15 上海华理生物医药有限公司 一种制备吉西他滨中间体的方法
CN102153601A (zh) * 2011-02-26 2011-08-17 湖南欧亚生物有限公司 一种高选择性的制备盐酸吉西他滨以及其中间体的方法
CN102603838B (zh) * 2012-02-14 2015-02-18 江苏八巨药业有限公司 一种制备吉西他滨盐酸盐的方法
CN103232508A (zh) * 2012-05-22 2013-08-07 湖北一半天制药有限公司 工业化盐酸吉西他滨的合成方法
WO2018124172A1 (ja) * 2016-12-28 2018-07-05 株式会社カネカ アルコール化合物の製造法
BR112019022470A2 (pt) 2017-04-26 2020-05-12 I. Kalman Thomas Composto, composição, e, método para tratamento de um indivíduo com câncer.
CN107200757B (zh) * 2017-06-29 2020-06-02 上海泓博智源医药股份有限公司 一种桥环氟代酯及其制备方法和应用
CN110511258A (zh) * 2018-05-21 2019-11-29 中国科学院上海药物研究所 一种胞嘧啶核苷的制备方法
CN109796506A (zh) * 2019-01-28 2019-05-24 江苏八巨药业有限公司 一种吉西他滨关键中间体的制备方法
CN111909229B (zh) * 2020-08-12 2023-05-05 福建瑞博奥科技有限公司 一种β-烟酰胺核糖氯化物的制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
CA1264738A (en) * 1984-12-04 1990-01-23 Eli Lilly And Company Treatment of tumors in mammals
ZA859008B (en) * 1984-12-04 1987-07-29 Lilly Co Eli The treatment of tumors in mammals
US4994558A (en) * 1986-12-24 1991-02-19 Eli Lilly And Company Immunoglobulin conjugates
US4814438A (en) * 1986-12-24 1989-03-21 Eli Lilly And Company Immunoglobulin conjugates of 2',2'-difluronucleosides
US5223608A (en) * 1987-08-28 1993-06-29 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
US5644043A (en) * 1988-02-16 1997-07-01 Eli Lilly And Company 2',3'-dideoxy-2',2'-difluoronucleosides and intermediates
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
US5401838A (en) * 1992-06-22 1995-03-28 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5606048A (en) * 1992-06-22 1997-02-25 Eli Lilly And Company Stereoselective glycosylation process for preparing 2'-Deoxy-2', 2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5256798A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
US5594124A (en) * 1992-06-22 1997-01-14 Eli Lilly And Company Stereoselective glycosylation process for preparing 2'-Deoxy-2',2'-difluoropyrimidine nucleosides and 2'-deoxy-2'-fluoropyrimidine nucleosides and intermediates thereof
US5426183A (en) * 1992-06-22 1995-06-20 Eli Lilly And Company Catalytic stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів
US5821357A (en) * 1992-06-22 1998-10-13 Eli Lilly And Company Stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoropurine and triazole nucleosides
US5371210A (en) * 1992-06-22 1994-12-06 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5401861A (en) * 1992-06-22 1995-03-28 Eli Lilly And Company Low temperature process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
NO932286L (no) * 1992-06-22 1993-12-23 Lilly Co Eli Stereoselektiv anion-glykosyleringsprosess
CA2105112C (en) * 1992-09-01 2005-08-02 Thomas C. Britton A process for anomerizing nucleosides
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride
US5521294A (en) * 1995-01-18 1996-05-28 Eli Lilly And Company 2,2-difluoro-3-carbamoyl ribose sulfonate compounds and process for the preparation of beta nucleosides
US5559222A (en) * 1995-02-03 1996-09-24 Eli Lilly And Company Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose
FR2808797A1 (fr) * 2000-05-09 2001-11-16 Hoechst Marion Roussel Inc Nouveaux derives de l'uridine, leur procede de preparation et leur application comme medicaments
EP1831236A4 (de) * 2004-12-30 2013-11-20 Hanmi Science Co Ltd Verfahren zur herstellung von 2'-deoxy-2',2'-difluorocytidin
WO2006092808A1 (en) * 2005-03-04 2006-09-08 Dabur Pharma Limited Intermediate and process for preparing of beta- anomer enriched 21deoxy, 21 ,21-difluoro-d-ribofuranosyl nucleosides

Also Published As

Publication number Publication date
AR052860A1 (es) 2007-04-04
AP2219A (en) 2011-03-22
CN101203524B (zh) 2011-06-15
EP1853616B1 (de) 2010-02-24
AP2007004098A0 (en) 2007-08-31
IL184957A0 (en) 2007-12-03
KR20070112774A (ko) 2007-11-27
ZA200706392B (en) 2008-09-25
AU2005328519B2 (en) 2012-03-01
AU2005328519A1 (en) 2006-09-08
US20060217547A1 (en) 2006-09-28
EA200701889A1 (ru) 2008-02-28
EA011558B1 (ru) 2009-04-28
GEP20094822B (en) 2009-11-10
TW200643027A (en) 2006-12-16
US20070208170A1 (en) 2007-09-06
NZ560735A (en) 2009-07-31
JP2008531680A (ja) 2008-08-14
US7235647B2 (en) 2007-06-26
WO2006092808A1 (en) 2006-09-08
EP1853616A1 (de) 2007-11-14
TWI333493B (en) 2010-11-21
CN101203524A (zh) 2008-06-18
CL2005003456A1 (es) 2008-05-02
BRPI0520050A2 (pt) 2009-11-17
UA88940C2 (ru) 2009-12-10
ES2341663T3 (es) 2010-06-24
MX2007010316A (es) 2008-02-19
CA2598895A1 (en) 2006-09-08
MY141378A (en) 2010-04-30
IL184957A (en) 2011-06-30
DE602005019626D1 (de) 2010-04-08

Similar Documents

Publication Publication Date Title
DE602004023910D1 (de) Verbundmaterial und Verfahren zu seiner Herstellung
DE602005015473D1 (de) Verfahren und mittel zur herstellung von hyaluronan
DE602004019594D1 (de) Magnetischer Verbundwerkstoff und Verfahren zu seiner Herstellung
DE60141983D1 (de) Verbundstützmittel, filtrationsmittel, kiespackungsmittel und sportplatzmittel sowie verfahren zur herstellung und verwendung derselben
EP1833992A4 (de) Pcv2-immunogene zusammensetzungen und verfahren zur herstellung solcher zusammensetzungen
DE602006014546D1 (de) Verfahren und vorrichtung zur herstellung von turbinen- oder kompressorrädern
DE602005010709D1 (de) Verfahren zur herstellung von pflanzenextrakten und heimtierfuttermitteln
DE60311103D1 (de) Auf norbornenester basierendes polymerisat und verfahren zu seiner herstellung
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
ATA18032003A (de) Aluminiumlegierung, bauteil aus dieser und verfahren zur herstellung des bauteiles
ATE458743T1 (de) Zwischenprodukt und verfahren zur herstellung von an beta-anomeren angereicherten 2'-desoxy,2',2'- difluor-d-ribufuranosylnukleosiden
DE102004007238B8 (de) Vorrichtung und Verfahren zur Herstellung von Sandwichplatten
DE602004028894D1 (de) Sensor und Verfahren zur Herstellung desselben
DE602005018353D1 (de) Fermentierter Tee und Verfahren zur Herstellung von fermentiertem Tee
ATE429820T1 (de) Durchlüftetes nahrungsmittel und verfahren zu seiner herstellung
DE502005008085D1 (de) Verfahren und Vorrichtung zur Herstellung von flächigen Elementen, insbesondere Bodenelementen
EP1848580A4 (de) Vorrichtung und verfahren zur herstellung von wellpappe und kaschiertem karton sowie darauf beruhende zusammensetzungen
ATE488508T1 (de) Verfahren zur herstellung von irbesartan und zwischenprodukte davon
ATE461919T1 (de) Verfahren zur herstellung von montelukast und zwischenprodukte dafür
DE502006009351D1 (de) Feinteiliges azopigment und verfahren zu seiner herstellung
ATE406372T1 (de) Verfahren zur herstellung von 3-o-geschützten morphinonen und 3-o-geschützten morphinondienolcarboxylaten
DE60330882D1 (de) Wischer und verfahren zur herstellung des wischers
ATE427040T1 (de) Verfahren zur herstellung von nahrungsmitteln und so hergestelltes nahrungsmittel
DE102005032999A8 (de) Sensor und Verfahren zur Herstellung desselben
DE602004026553D1 (de) Verfahren zur herstellung von polyorganosiloxanteilchen und zur herstellung von siliciumdioxidteilchen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties